Lefamulin
- CAS No.
- 1061337-51-6
- Chemical Name:
- Lefamulin
- Synonyms
- 2-[[(1R,2R,4R)-4-Amino-2-hydroxycyclohexyl]thio]acetic acid (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl ester;BC 3781;Lefamulin;Lefamulin(BC-3781);Lefamulin, 10 mM in DMSO;(3aR,4R,5R,7S,8S,9R,9aS,12R)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-(((1R,2R,4R)-4-amino-2-hydroxycyclohexyl)thio)acetate;Acetic acid, 2-[[(1R,2R,4R)-4-amino-2-hydroxycyclohexyl]thio]-, (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl ester
- CBNumber:
- CB93039318
- Molecular Formula:
- C28H45NO5S
- Molecular Weight:
- 507.73
- MDL Number:
- MFCD28963989
- MOL File:
- 1061337-51-6.mol
- MSDS File:
- SDS
Boiling point | 618.6±55.0 °C(Predicted) |
---|---|
Density | 1.19±0.1 g/cm3(Predicted) |
storage temp. | 2-8°C |
solubility | DMF: 16 mg/mL; DMSO: 12 mg/mL; Ethanol: 3 mg/mL; PBS (pH 7.2): 0.25 mg/mL |
form | A solid |
pka | 14.45±0.60(Predicted) |
color | White to off-white |
InChIKey | KPVIXBKIJXZQJX-FCEONZPQSA-N |
SMILES | C(O[C@@H]1C[C@](C=C)(C)[C@@H](O)[C@H](C)[C@@]23CC[C@@H](C)[C@]1(C)[C@]2([H])C(=O)CC3)(=O)CS[C@@H]1CC[C@@H](N)C[C@H]1O |
FDA UNII | 21904A5386 |
ATC code | J01XX12 |
UNSPSC Code | 51101500 |
Lefamulin price
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
DC Chemicals | 007448 | Lefamulin(BC-3781) | 1061337-51-6 | 004 | $450 | 2021-12-16 | Buy |
DC Chemicals | DC8172 | Lefamulin(BC-3781) >98% | 1061337-51-6 | 100mg | $1000 | 2021-12-16 | Buy |
DC Chemicals | DC8172 | Lefamulin(BC-3781) >98% | 1061337-51-6 | 250mg | $1700 | 2021-12-16 | Buy |
Lefamulin Chemical Properties,Uses,Production
Uses
Lefamulin is an antibiotic medication used in the treatment of adults with community-acquired bacterial pneumonia.
Biological Activity
Lefamulin inhibits bacterial protein synthesis by binding to the 50S subunit of the bacterial ribosome. Specifically, it binds to the peptidyl transferase center of the ribosome and inhibits the transfer of amino acids to growing polypeptide chains, which leads to the inhibition of bacterial protein synthesis and bacterial death. Lefamulin is active against a wide range of Gram-positive bacteria, including Streptococcus pneumoniae, Staphylococcus aureus, and methicillin-resistant S. aureus (MRSA), as well as some atypical bacteria such as Legionella species. It has also been shown to have activity against some Gram-negative bacteria, including Haemophilus influenzae and Moraxella catarrhalis.
Lefamulin Preparation Products And Raw materials
Raw materials
1of2
Preparation Products
Lefamulin Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 32161 | 58 |
CR Corporation Limited | +8613062833949 | fred.wen@crcorporation.cn | China | 8647 | 58 |
Hefei TNJ Chemical Industry Co.,Ltd. | +86-0551-65418684 +8618949823763 | sales@tnjchem.com | China | 25356 | 58 |
Nanjing Doge Biomedical Technology Co., Ltd | +86-25-58227606 +86-15305155328 | sales@dogechemical.com | China | 4128 | 58 |
TargetMol Chemicals Inc. | support@targetmol.com | United States | 38631 | 58 | |
Zhengzhou Anbu Chem Co.,Ltd | +86-0371-88006763; +8615988602810 | sales@anbuchem.com | China | 2998 | 58 |
Shanghai Qianyi New Material Co., Ltd. | +8618083322317 | 3391883138@qq.com | China | 878 | 58 |
Wuhan Topule Biopharmaceutical Co., Ltd | +8618327326525 | masar@topule.com | China | 8467 | 58 |
Shanghai Likang New Materials Co., Limited | +86-16631818819 +86-17736933208 | 3684455296@qq.com | China | 9300 | 58 |
XIAMEN AMITY INDUSTRY AND TRADE CO., LTD. | +8618950047208 | ellena@amitychem.com | China | 43416 | 58 |
Related articles
- A semisynthetic pleuromutilin antibiotic: Lefamulin
- Lefamulin, a semisynthetic pleuromutilin antibiotic, has been approved by the FDA for IV and oral treatment of community-acqui....
- Jan 5,2024